Mark your calendars for PER’s 8th Annual Live Medical Crossfire®: Hematologic Malignancies on July 20th! Register for FREE using my last name as a discount code and don’t miss this #CME opportunity! bit.ly/43gPxpg #gotoPER #MXH #HemeOnc
Barbara Pro Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Amer Zeidan MBBS,MHS ‏عامر زيدان

Entertaining collegial debate alert! Maximilian Stahl Dana-Farber News dives into the role for frontline luspatercept use for #MDSsm ! 🚀 Energizing insights, engaging discussion! 👇 ! #MedTwitter MD Education US Focus 5th annual meeting 👏👏🎊🎊It’s all about the Win 😂👏

The impact of molecular ontogeny in AML treated with HMA+VEN is unknown. We found that Secondary ontogeny is selectively responsive to VEN added to HMA and the addition of VEN has no clinical benefit in TP53-mutated AML. rdcu.be/dCCZI Leukemia Journal #amlsm Dana-Farber News

Dr. John Forrest Jr. died last week surrounded by family.

His research focused on pathophysiology & treatment of fluid & electrolyte disorders. Forrest eventually became the only principal investigator in the world to be on five NIH T35 training grants.
medicine.yale.edu/internal-medic…

What is the optimal therapy in molecularly defined secondary AML?
Our multicenter study tries to answer this important question. Pulisehd today in Leukemia. rdcu.be/dy7hW
Thanks to all collaborators and my good friend and mentor Maximilian Stahl

#AMLsm

We are about to start our FREE annual VJHemOnc updates of the #MDSsm highlights from #ASH2023 . Not too late to join. We have 16 talks each 5-min by abstract authors followed by debate/discussion of classification, risk stratification and current/investigational therapies.

Post-ASH 2023 #MDS Highlights: panel discussion on non-disease modifying agents in LR-MDS w/ Amer Zeidan MBBS,MHS ‏عامر زيدان Maximilian Stahl María Díez Campelo Valeria Santini

Join us here: tinyurl.com/yc6zcuvs

We’re hosting a Post-ASH Virtual Highlights Series, featuring presentations & discussions on selected abstracts from #ASH23 , w/ leading #HemOnc experts 💻🩸

Join us for our #MDS session, chaired by Amer Zeidan MBBS,MHS ‏عامر زيدان

Check out the agenda & REGISTER NOW 👉 vjhemonc.com/feature/post-a…

Thank you for the invitation Amer Zeidan MBBS,MHS ‏عامر زيدان and AA&MDSIF. It was great to be back Yale Cancer Center. New Haven and Yale School of Medicine always evoke the best memories for me. Nice to see Amer Zeidan MBBS,MHS ‏عامر زيدان, Nikolai Podoltsev, Mina L Xu and Lourdes Mendez.

Great to see this out! This was my first investigator initiated trial that I wrote during my Oncology fellowship Memorial Sloan Kettering Cancer Center. Thank you Abdel-Wahab Lab for giving me the opportunity to participate in this story.

Looking forward to speaking there about treatment of lower risk MDS